Loading ...

Stock Quote 1734

1734 Stock Price Today

1734 Price History

1734 Stock Price History

1734 History

Last Price 1734

Close Price 1734

Day Change 1734

After Hours Quote 1734

Open Price 1734

Day Range 1734

Year Range 1734

Projected Yield 1734

Market Cap 1734

Stock Volume 1734

Average Volume 1734

Forward Price 1734

PE for 1734

PB for 1734

PS for 1734

PCF for 1734

price earnings ratio 1734

price to book ratio 1734

price to sales ratio 1734

price to cash flow ratio 1734

Stock Quote Sinphar Pharmaceutical Co Ltd

Sinphar Pharmaceutical Co Ltd Stock Price today

Sinphar Pharmaceutical Co Ltd Price history

Sinphar Pharmaceutical Co Ltd Stock Price history

Sinphar Pharmaceutical Co Ltd history

Last Price Sinphar Pharmaceutical Co Ltd

Close Price Sinphar Pharmaceutical Co Ltd

Day Change Sinphar Pharmaceutical Co Ltd

After Hours Quote for Sinphar Pharmaceutical Co Ltd

Open Price Sinphar Pharmaceutical Co Ltd

Day Range Sinphar Pharmaceutical Co Ltd

Year Range Sinphar Pharmaceutical Co Ltd

Projected Yield Sinphar Pharmaceutical Co Ltd

Market Cap Sinphar Pharmaceutical Co Ltd

Stock Volume Sinphar Pharmaceutical Co Ltd

Average Volume Sinphar Pharmaceutical Co Ltd

Forward Price Sinphar Pharmaceutical Co Ltd

pe Sinphar Pharmaceutical Co Ltd

pb Sinphar Pharmaceutical Co Ltd

ps Sinphar Pharmaceutical Co Ltd

pcf Sinphar Pharmaceutical Co Ltd

price earnings ratio Sinphar Pharmaceutical Co Ltd

price to book ratio Sinphar Pharmaceutical Co Ltd

price to sales ratio Sinphar Pharmaceutical Co Ltd

price to cash flow ratio Sinphar Pharmaceutical Co Ltd

What Does This Company Do?
Sinphar Pharmaceutical Co., Ltd. operates in pharmaceutical segment. Its product portfolio comprises of therapeutic medicines, functional foods, medical equipments and cosmetics. The company specializes in dermatological topical medicine segment.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Employees
984
Stock Style
Small Growth

Key Stats  1734 More...

Key Stats 1734

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .



Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Sponsor Center

Analysis  1734 - Sinphar Pharmaceutical Co Ltd More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

News  1734 - Sinphar Pharmaceutical Co Ltd More...

More reports 1734 - Sinphar Pharmaceutical Co LtdMore...

Click above to view more mutual fund data and stats for 1734 - Sinphar Pharmaceutical Co Ltd.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   1734 More ...

Ownership 1734

DFA Emerging Markets Core Equity I
DFA Emerging Markets Small Cap I
SPDR S&P Emerging Markets Small Cap
JHancock Emerging Markets NAV
CREF Stock
Stock Price Quote: 1734 Sinphar Pharmaceutical Co Ltd - XTAI - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: sngyo - Sinpas Gayrimenkul Yatirim Ortakligi A.S.  |  Next: snn - Sintana Energy Inc